
Bayer
German multinational life-science company operating in pharmaceuticals, consumer health, crop science, seeds, and agricultural biotechnology.
Last updated November 11, 2026
AI crawler reads
286requests
7AI- OpenAI192
- Perplexity44
- Amazon24
- Shape9
- Anthropic8
- +29
- Profile
- 175
- Controversies
- 35
- JSON · MD
- 0
- First read
- Oct 29, 2026
- Latest read
- Nov 17, 2026
From this site's server log
Overview
Bayer is a German multinational life-science company headquartered in Leverkusen. Its principal businesses are Pharmaceuticals, Consumer Health, and Crop Science. The company develops prescription medicines, over-the-counter health products, crop-protection chemicals, agricultural seeds, traits, and digital farming technologies. Bayer sells globally through a mixture of proprietary brands, prescription products, agricultural distribution channels, licensing arrangements, and regional consumer-health portfolios. The company began in 1863 in Barmen, now part of Wuppertal, as a partnership between Friedrich Bayer, a commercial dyestuffs merchant, and Johann Friedrich Weskott, a dyer. Its early expertise in aniline and related chemistry created a platform for expansion beyond textile dyes. Bayer later moved production to the Leverkusen area, which became closely associated with the company and eventually developed into the city of Leverkusen. Bayer became internationally recognizable through pharmaceutical products. Aspirin, introduced under Bayer's trademark in 1899, became one of the world's best-known medicines and remains a central part of the company's historical identity. The company also commercialized or developed products including heroin, phenobarbital, the antibacterial drug Prontosil, and the antiparasitic compound suramin. Some of these products belong to the history of medicine rather than Bayer's current portfolio, and heroin is now an illicit addictive substance rather than a Bayer offering. In 1925, Bayer joined BASF, Hoechst, Agfa, and other chemical companies to form IG Farben. That conglomerate was deeply involved in the German war economy and used forced labor during the Nazi period. After the Second World War, Allied authorities dismantled IG Farben, and Bayer was re-established as an independent company in 1951. The company's postwar growth included pharmaceuticals, polymers, diagnostics, consumer products, and agricultural chemicals. Bayer expanded through acquisitions, including Miles Laboratories in 1978 and Monsanto in 2018. The Monsanto transaction substantially increased Bayer's agricultural-seeds and crop-science capabilities, but it also made Bayer responsible for extensive litigation concerning glyphosate-based Roundup herbicides and alleged cancer risks. The resulting legal, financial, and reputational pressures have been among the defining issues of Bayer's contemporary history. Today, Bayer presents itself as a science-based company focused on health and nutrition. Its pharmaceutical activities include cardiovascular, renal, women's-health, specialty-care, radiology, and ophthalmology products. Consumer Health markets brands such as Aspirin, Aleve, Claritin, and Bepanthen in relevant countries. Crop Science supplies herbicides, fungicides, insecticides, seeds, traits, and agricultural data and services. The Bayer Cross remains the company's principal corporate symbol, while the business portfolio continues to be shaped by patent cycles, clinical development, agricultural regulation, litigation, and portfolio restructuring.
History
Bayer was founded in 1863 in Barmen by Friedrich Bayer and Johann Friedrich Weskott as a dyestuffs partnership. The business used the expanding possibilities of aniline chemistry to develop textile colorants and related chemicals. Production moved first to Elberfeld and later to the Leverkusen area, where the company established the industrial base that still defines its identity. The company entered pharmaceuticals in the late nineteenth and early twentieth centuries. Bayer registered Aspirin as a trademark in 1899 and introduced the Bayer Cross as a corporate mark in 1904. It also marketed heroin as a medicine between 1898 and 1910, commercialized the barbiturate Veronal, and contributed to the development of phenobarbital. During the 1930s, Bayer researchers associated with IG Farben developed Prontosil, a landmark sulfonamide antibacterial drug. Gerhard Domagk received the 1939 Nobel Prize in Physiology or Medicine for the discovery of its antibacterial effects, although Nazi authorities prevented him from accepting the award at the time. In 1925, Bayer became part of IG Farben, a large German chemical conglomerate. IG Farben supported the Nazi war economy, used forced labor, and was connected with concentration-camp production and medical experimentation. After the Second World War, Allied authorities seized and dismantled IG Farben. Bayer was reconstituted in 1951 and later adopted the name Bayer AG in 1972. Its postwar expansion made it a major producer of pharmaceuticals, polymers, diagnostics, consumer-health goods, and agricultural chemicals. The company's history also includes difficult legacies: former IG Farben personnel returned to senior positions after the war, and Bayer later faced criticism over its predecessor's wartime conduct. Bayer's postwar portfolio broadened through product development and acquisitions. It brought chlorpromazine to the German market in the 1950s, expanded consumer-health operations through the purchase of Miles Laboratories in 1978, and developed or acquired brands in vitamins, antacids, insect repellents, and hemophilia treatment. Contaminated clotting-factor products sold during the early AIDS epidemic resulted in a major public-health controversy and subsequent settlements. Other product controversies included the withdrawal of Baycol in 2001 and disputes concerning the Primodos hormone pregnancy test. The modern company is organized around pharmaceuticals, consumer health, and crop science. The 2018 acquisition of Monsanto made Bayer a leading agricultural-seeds and crop-protection company. That transaction also transferred responsibility for Roundup-related litigation. Jury verdicts, appeals, settlements, and continuing claims concerning glyphosate have affected Bayer's reputation, investor relations, and strategic priorities. In the 2020s, management emphasized simplifying the organization, improving operational performance, managing litigation, and maintaining investment in pharmaceutical and agricultural innovation.
- 2018
Monsanto acquisition closes
[1]Bayer completes the Monsanto transaction after regulatory approval.
- 2016
Monsanto acquisition is agreed
[1]Bayer announces an agreement to acquire Monsanto.
- 2001
Baycol is withdrawn
[1]Bayer removes the statin cerivastatin from the market after serious safety reports.
- 1978
Miles Laboratories is acquired
[1]Bayer acquires Miles Laboratories and gains brands including Alka-Seltzer, One-A-Day, and Flintstones vitamins.
- 1972
The company adopts the Bayer AG name
[1]Farbenfabriken Bayer AG changes its name to Bayer AG.
- 1951
Bayer is re-established
[1]Following the dissolution of IG Farben, Bayer is reconstituted as an independent company.
- 1932
Prontosil is developed
[1]Bayer researchers develop Prontosil, an important early systemic antibacterial medicine.
- 1925
Bayer joins IG Farben
[1]Bayer becomes part of the IG Farben chemical conglomerate.
- 1904
Bayer Cross is trademarked
[1]The circular Bayer Cross logo receives trademark protection.
- 1899
Aspirin trademark is introduced
[1]Bayer launches acetylsalicylic acid under the Aspirin trademark.
Products and positioning
Science for a better life
Over-the-counter medicine · 1899
Aspirin
Bayer's best-known historical product is acetylsalicylic acid sold under the Aspirin trademark. It is used in pain relief and, at appropriate doses and under medical guidance, in the prevention of certain cardiovascular events. The word is generic in some markets but remains a Bayer trademark in others.
Prescription medicine
Xarelto
Xarelto is the brand name for rivaroxaban, an oral anticoagulant used for several blood-clotting and cardiovascular indications. It is one of Bayer's major pharmaceutical products and is commercialized with a regional partner in some markets.
Ophthalmology medicine
Eylea
Eylea is an ophthalmic biologic used for retinal and other eye diseases associated with abnormal blood-vessel growth or leakage. It is part of Bayer's specialty-pharmaceutical and ophthalmology portfolio.
Consumer health
Claritin
Claritin is a consumer-health allergy brand based primarily on loratadine. It is sold in multiple countries in formulations intended to relieve symptoms of seasonal or perennial allergic rhinitis and related allergies.
Agricultural science
Crop Science
Bayer Crop Science combines crop-protection products with seeds, plant traits, biological approaches, and digital farming tools. Its portfolio supports weed, insect, and disease management as well as crop productivity across major agricultural markets.
Herbicide
Roundup
Roundup is a glyphosate-based herbicide brand acquired through Monsanto. It has been commercially important in weed control but has also generated extensive litigation alleging links between glyphosate exposure and cancer. Bayer disputes the allegations and continues to manage the legal and regulatory consequences.
Antibacterial medicine · 1932
Prontosil
Prontosil was an early sulfonamide antibacterial medicine developed by researchers associated with Bayer's laboratories in the 1930s. Its development helped establish systemic antibacterial chemotherapy, although it is no longer a central current Bayer product.
Controversies
2026
Monsanto secures defense verdict in Roundup trial
In a Roundup-related trial, a Missouri jury returned a unanimous defense verdict in favor of Monsanto, the company associated with Bayer. The case involved claims of design defect, fraud and negligence. The verdict resolved the trial in Monsanto's favor on those claims. The event was reported as Monsanto's first Roundup trial win since a Supreme Court ruling referenced in the source headline.
2026
Jury rules for Bayer in Roundup cancer trial
A Missouri jury unanimously ruled in favor of Bayer in a trial concerning claims that Roundup caused cancer in three women. The women alleged that they developed non-Hodgkin lymphoma after regularly using the weedkiller. The jury's decision resolved the trial in Bayer's favor.
2023
Bayer recalls one lot of Vitrakvi over microbial contamination
Bayer voluntarily recalled one lot of its cancer drug Vitrakvi in the United States after microbial contamination was observed during routine stability testing. Bayer identified a fungus as the source and said ingestion could pose a risk of invasive fungal infections or life-threatening pneumonia for immunocompromised patients.
2022
Bayer and Janssen sue Micro Labs over Xarelto patents
Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals Inc. filed a patent-infringement case against Micro Labs LTD and Micro Labs USA Inc. concerning Xarelto. The plaintiffs seek declaratory and injunctive relief and expenses.
2022
Bayer sues Perrigo over Nasonex advertising
Bayer Healthcare LLC filed a complaint against Perrigo Company plc alleging that claims in Nasonex labeling and advertisements, including that it works twice as fast as other anti-allergy medications, are false and misleading. Bayer seeks an injunction, corrective advertising and damages; the source does not report a court determination.
2022
Lawsuit alleges defects in Bayer's Essure device
A plaintiff sued Bayer and related entities, alleging that defects in the Essure birth control device and its manufacturing could harm users. The allegations are described in the complaint; the article does not report a court determination.
2022
Los Angeles files PCB contamination lawsuit against Monsanto
The city of Los Angeles sued Monsanto and two other companies seeking compensation for past and future costs related to PCB contamination of waterways. The city alleges that PCBs continue to enter local waterways and soils. Bayer said it was reviewing the lawsuit and believed it was without merit, and denied that Monsanto manufactured, used, or disposed of PCBs in Los Angeles waters.
2021
Jury awards $62 million in PCB exposure case
A King County jury awarded $62 million in damages to eight people harmed by exposure to PCBs at Sky Valley Education Center. The jury decided Bayer had done too little to warn the public about PCBs. Bayer Pharmaceuticals said it disagreed with the verdict and planned to appeal.
2021
LHC Group files complaint against Bayer over Essure
LHC Group filed a complaint against Bayer and others concerning the allegedly defective Essure birth-control device. The plaintiff alleged that Bayer negligently monitored and reported complications and continued marketing the product as safe and effective; these are allegations in the complaint, not a court determination.
2020
Jury orders Bayer and BASF to pay damages over dicamba herbicide damage
A U.S. jury found Bayer and BASF liable in a farmer's case alleging that dicamba herbicide produced by the companies drifted onto and severely damaged his peach orchard. The jury awarded $15 million in actual damages and $250 million in punitive damages. Bayer said it would appeal. The event was reported in February 2020.
Marketing campaigns
- 2020Bayer launches Saudi recruitment campaign
SA
Bayer launched the digitally led #MoveForwardwithBayer campaign in Saudi Arabia to recruit local talent. The company said it aims to recruit more than 140 additional team members by 2021.
Brand decisions
2024
Bayer implements Dynamic Shared Ownership operating modelStrategyBackground
Bayer said it began using its Dynamic Shared Ownership (DSO) operating model globally, aiming to reduce management layers and bureaucracy, streamline the organization, and speed up decision-making.
2024
Bayer introduces Iberogast in the United StatesStrategyBackground
Bayer Consumer Health introduced Iberogast, a plant-based digestive relief product, to the United States. The article says it is available on Amazon and at major retailers.
2024
Bayer advances global restructuring and job reductionsStrategyBackground
Bayer said it is adjusting its structure across its three divisions, with some positions being eliminated or redesigned and new roles created. Employees were invited to indicate whether they wished to be considered for severance benefits as the company prepared for layoffs.
2023
Bayer announces acquisition of Blackford AnalysisM&ABackground
Bayer announced its acquisition of Blackford Analysis Ltd., a global imaging AI platform and solutions provider. The transaction was expected to close later in 2023, subject to customary closing conditions, including a UK competition regulator condition precedent.
2022
Bayer announces sale of its Environmental Science Professional businessM&ABackground
Bayer said it is selling its Environmental Science Professional business to private equity firm Cinven for $2.6 billion. The sale was expected to close in the second half of 2022.
2022
Bayer suspends most operations in Russia and BelarusStrategyBackground
Bayer suspended all activities in Russia and Belarus except those involving vital products for health and agriculture.
2021
Bayer announces acquisition agreements for Noria and PSMA TherapeuticsM&ABackground
Bayer announced that it had entered into acquisition agreements with Noria Therapeutics and PSMA Therapeutics, including rights to an actinium-225-labeled small molecule targeting PSMA for prostate cancer treatment.
2020
Bayer announces acquisition of AskBioM&ABackground
Bayer announced that it would acquire Asklepios BioPharmaceutical (AskBio), expanding its cell and gene therapy capabilities.
Recent events
Bayer raises 2026 adjusted EBITDA outlook[42]
Reported
Bayer raised its 2026 outlook for currency-adjusted EBITDA before special items, citing stronger pharmaceutical performance in the first nine months of the year.
- Unconfirmed
Bayer raises outlook after pharma recovery[43]
Reported
A WSJ headline reports that Bayer raised its outlook after a recovery in its pharma business; the supplied source does not provide further details.
Monsanto secures defense verdict in Roundup trial[25]
Reported
A Missouri jury returned a unanimous defense verdict in Monsanto's favor in a Roundup-related trial involving claims of design defect, fraud and negligence.
Jury rules for Bayer in Roundup cancer trial[27]
Reported
A St. Louis jury unanimously ruled for Bayer-owned Monsanto in a trial over claims that Roundup caused cancer. Bayer denied the claims.
Jury rules for Bayer in Roundup cancer trial[26]
Reported
A Missouri jury unanimously sided with Bayer in a trial over claims that Roundup caused cancer in three women. The women had alleged that they developed non-Hodgkin lymphoma after regularly using the weedkiller.
Phylo and Bayer announce AI drug-discovery research partnership[44]
Reported
Phylo announced a partnership with Bayer to use Phylo’s Biomni Lab AI platform in drug-discovery research, including workflows aimed at assembling scientific literature and omics evidence. The announcement was unclear about whether Bayer’s access had begun.
- Unconfirmed
Bayer CEO cut managers by 70%[45]
Reported
Fortune reports that Bayer's CEO has cut the number of managers at the company by 70%, with the article indicating the company now faces the next stage of the effort.
- Unconfirmed
Bayer to build $2.2 billion drug manufacturing plant in New Albany[46]
Reported
Pharmaceutical company Bayer plans to build a $2.2 billion drug manufacturing plant in New Albany, as reported by wosu.org.
Bayer and Soufflé Therapeutics announce siRNA collaboration[47]
Reported
Bayer and Soufflé Therapeutics announced a strategic collaboration and global licensing agreement to advance a heart-targeted siRNA therapy for a form of dilated cardiomyopathy.
- Unconfirmed
Bayer obtains exclusive rights to AlphaBio bioinsecticide[48]
Bayer entered into an agreement with AlphaBio Control granting Bayer exclusive rights to a bioinsecticide for arable crops. The product launch is planned for 2028.
Sources131 sources
- 1Bayeren.wikipedia.org
- 2Bayer corporate websitebayer.com
- 3Bayer Board of Managementbayer.com
- 4Bayer launches Saudi recruitment campaignargaam.com
- 5Bayer implements Dynamic Shared Ownership operating modelfinance.sina.com.cn
- 6Bayer introduces Iberogast in the United Statesfinanznachrichten.de
- 7Bayer advances global restructuring and job reductionsnewstribune.com
- 8Bayer announces acquisition of Blackford Analysisitnonline.com
- 9Bayer announces sale of its Environmental Science Professional businessyahoo.com
- 10Bayer suspends most operations in Russia and Belarusabc.az
- 11Bayer announces acquisition agreements for Noria and PSMA Therapeuticsprnasia.com
- 12Bayer announces acquisition of AskBioprnasia.com
- 13Australian farmer sues Monsanto over Roundupabc.net.au
- 14Jury orders Bayer and BASF to pay damages over dicamba herbicide damagesc.stock.cnfol.com
- 15Bayer agrees to draft settlement terms in Roundup casesipolitics.ca
- 16D.C. sues Monsanto over PCB pollution allegationswtop.com
- 17Bayer announces settlements of Roundup, dicamba and PCB litigationlankaweb.com
- 18Bayer reaches settlements over Roundup, dicamba and PCB claimscourthousenews.com
- 19Bayer reaches settlements over Roundup, dicamba and PCB claimsnbcnews.com
- 20California appeals court upholds Monsanto liability and reduces awardnbcbayarea.com
- 21California appeals court upholds Roundup verdict and reduces damagesmanitobacooperator.ca
- 22California appeals court upholds Roundup verdict and reduces damagesibtimes.com
- 23Bayer asks California Supreme Court to review Roundup verdictfoxbusiness.com
- 24Bayer asks California Supreme Court to review Roundup verdicthortweek.com
- 25Monsanto secures defense verdict in Roundup trialrttnews.com
- 26Jury rules for Bayer in Roundup cancer trialdw.com
- 27Jury rules for Bayer in Roundup cancer trialksevradio.com
- 28Jury rules for Bayer in Roundup cancer trialtheepochtimes.com
- 29Jury awards $62 million in PCB exposure caseens-newswire.com
- 30Bayer and Janssen sue Micro Labs over Xarelto patentslawstreetmedia.com
- 31Bayer sues Perrigo over Nasonex advertisinglawstreetmedia.com
- 32Bayer sues Perrigo over Nasonex advertisingdrleonardcoldwell.com
- 33Bayer sues Perrigo over Nasonex advertisingnewsday.com
- 34Bayer recalls one lot of Vitrakvi over microbial contaminationyahoo.com
- 35Lawsuit alleges defects in Bayer's Essure devicelawstreetmedia.com
- 36Los Angeles files PCB contamination lawsuit against Monsantolaist.com
- 37LHC Group files complaint against Bayer over Essurelawstreetmedia.com
- 38Bayer Vietnam executive fined over internal documentnews.tuoitre.vn
- 39Bayer appeals Roundup cancer verdictdw.com
- 40Bayer fined over Supradyn Kids advertisingnutraingredients.com
- 41Bayer sues Glenmark over generic Finaceapmlive.com
- 42拜耳上调2026年调整后EBITDA展望econotimes.com
- 43拜耳因制药业务复苏上调展望news.google.com
- 44Phylo与拜耳宣布人工智能药物发现研究合作econotimes.com
- 45拜耳首席执行官将经理人数削减70%news.google.com
- 46拜耳拟投资22亿美元在新奥尔巴尼建设药品制造工厂news.google.com
- 47拜耳与 Soufflé Therapeutics 宣布 siRNA 合作finanznachrichten.de
- 48Bayer获得AlphaBio生物杀虫剂的独家权利wisconsinagconnection.com
- 49拜耳与 Trinity Agtech 宣布碳倡议合作finanznachrichten.de
- 50健康元与拜耳签署COPD药物中国独家授权协议nbd.com.cn
- 51拜耳与BharatCares推出Better School Programnews.webindia123.com
- 52AgPlenus与拜耳宣布除草剂合作finanznachrichten.de
- 53FDA批准Bayer的Ultravist用于增强乳房X线摄影itnonline.com
- 54拜耳与Oerth Bio宣布开展作物保护合作finanznachrichten.de
- 55拜耳宣布Bill Anderson将出任新任首席执行官pmlive.com
- 56拜耳马拉维推出DKC80-23玉米种子品种maravipost.com
- 57拜耳与 Perdue AgriBusiness 宣布再生农业合作prnewswire.com
- 58拜耳在印度推出 Kerendiaeconomictimes.indiatimes.com
- 59拜耳推出 ForGround 数字农业平台ibtimes.com
- 60Grünenthal宣布从拜耳收购Nebidoprnewswire.com
- 61IQ-AI 软件在 Bayer Calantic 平台上线themarketreporter.co.uk
- 62拜耳宣布推出Calantic数字化解决方案health.people.com.cn
- 63UPL与拜耳达成全球螺螨酯供应合作prnewswire.com
- 64Bayer签署“零饥饿私营部门承诺”english.news.cn
- 65Bayer 停止 eliapixant 的开发finanznachrichten.de
- 66拜耳推出Testing4Ag测试平台engineeringnews.co.za
- 67拜耳与SAME基金会启动新冠救助基金bizcommunity.com
- 68Crystal Crop 完成收购 Bayer 四项杂交种子业务economictimes.indiatimes.com
- 69Huma与拜耳合作开展肺癌研究prnewswire.com
- 70EarthOptics 完成 1,030 万美元 A 轮融资prnewswire.com
- 71FDA批准Astepro转为非处方销售finanznachrichten.de
- 72GreenLight Biosciences收购拜耳外用RNA知识产权相关权利prnewswire.com
- 73拜耳发布护肤品牌倍润prnasia.com
- 74ESSA Pharma 与拜耳达成临床合作及供应协议prnewswire.com
- 75拜耳中国获评“中国杰出雇主2021”prnasia.com
- 76FDA批准Verquvo用于治疗成人症状性慢性心力衰竭finanznachrichten.de
- 77拜耳与 Arogya Finance 宣布在印度推出 Eylea 支付合作计划aninews.in
- 78拜耳荣获 2020 可持续发展杰出贡献奖prnasia.com
- 79BlockApps推出TraceHarvest网络capitalpress.com
- 80拜耳宣布提升北京工厂产能prnasia.com
- 81Bayer 与 Recursion 就纤维化疾病开展战略合作thepharmaletter.com
- 82拜耳与华领医药达成战略合作开发多格列艾汀tech.sina.com.cn
- 83FDA批准Lampit用于儿童恰加斯病治疗finanznachrichten.de
- 84拜耳携手连锁药房打造皮科健康中心prnasia.com
- 85拜耳与Prospera合作开发温室种植数字解决方案3blmedia.com
- 86拜耳与MassBio推出联合导师计划prnasia.com
- 87WaveForm Diabetes 与拜耳达成中国市场血糖监测解决方案商业协议prnewswire.com
- 88拜耳与PHRI合作开展COVID-19临床研究pharmatimes.com
- 89药明生物完成收购拜耳制造工厂prnewswire.com
- 90拜尔宣布与AI药物筛选企业合作,项目金额可达2.4亿欧元leiphone.com
- 91拜耳收购AskBio扩大细胞和基因疗法的创新基础--健康・生活--人民网health.people.com.cn
- 92拜耳中国捐赠总值超1000万元医疗物资与资金finance.sina.com.cn
- 93国家出手去除医药“带金销售”毒瘤 拜耳降血糖药降价超90%finance.sina.com.cn
- 94扩大产能 药明生物收购拜耳旗下工厂finance.sina.com.cn
- 95药明生物(02269.HK)与拜耳就一家位于德国的生物制剂工厂达成收购协议finance.sina.com.cn
- 96药明生物(02269)收购位于德国的生物药制剂制造工厂的设施资产finance.sina.com.cn
- 97药明生物收购拜耳旗下工厂 为其首个欧洲生物制剂厂finance.sina.com.cn
- 98药明生物收购拜耳位于德国伍珀塔尔的生物药原液厂prnasia.com
- 99药明生物收购德国生物制剂工厂,欧洲市场布局提速finance.sina.com.cn
- 100中企收购德国拜耳一间药厂 将用于新冠疫苗生产finance.sina.com.cn
- 101中企收购德国拜耳一间药厂 将用于新冠疫苗生产_杭州网news.hangzhou.com.cn
- 102中企收购德国拜耳一间药厂 将用于新冠疫苗生产_中国江苏网news.jschina.com.cn
- 103Bayer Announces National Sponsorship of the American Heart Association and the American Diabetes Association's Know Diabetes by Heart initiativeprnewswire.com
- 104Bayer appeals $20.5 mln Roundup ruling to California Supreme Courtfinancialpost.com
- 105Bayer donates €1.5 million in value for coronavirus-hit areasvir.com.vn
- 106Bayer fails to overturn Roundup verdictdw.com
- 107Bayer launches ‘Science for Better’ campaign rooting for improved livelihoods through sciencecapitalfm.africa
- 108Bayer launches groundbreaking collaboration with Perdue AgriBusinessthepoultrysite.com
- 109Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosisdigitalhealthnews.eu
- 110Bayer launches sustainable agriculture platform focused on collaborationhortidaily.com
- 111Bayer Loses Another Appeal Against Roundup Cancer Verdictibtimes.com
- 112Bayer loses appeal in California Roundup cancer verdictmalaymail.com
- 113Bayer loses appeal of $86M verdict for Roundup weedkiller cancer claimdailymail.com
- 114Bayer partners with Agribazaar to provide solutions to smallholder farmersindianexpress.com
- 115Bayer partners with Agribazaar to provide solutions to smallholder farmersbusiness-standard.com
- 116Bayer partners with China firm to market dronesmanilatimes.net
- 117Bayer partners with Maharashtra government to set up 100-bed corona care facility in Aurangabadeconomictimes.indiatimes.com
- 118Bayer Reaches $10 Billion Settlement Over Roundup Cancer Lawsuits | Big Dog 95.9bigdog959.iheart.com
- 119Bayer reaches $10.5 billion settlement over weedkiller Roundupfoxbusiness.com
- 120Bayer Reaches Revised Settlement to Address Roundup Allegationslawstreetmedia.com
- 121Bayer wins fifth Roundup verdict in a row after some high-profile lossesabajournal.com
- 122Bayer wins first Roundup cancer trial after US Supreme Court ruling: What changes for 65,000 claimants? | Company Business Newslivemint.com
- 123Burlington School District Sues Monsanto Over PCB Contamination | Seven Dayssevendaysvt.com
- 124Chicago Sues Monsanto for Polluting City’s Air, Water, Soil with Toxic Chemicalsnews.wttw.com
- 125City of Los Angeles Sues Monsanto for Lasting Damages Caused by Toxic PCBslawstreetmedia.com
- 126Delaware sues Monsanto over PCB damage to the statedelawarepublic.org
- 127Los Angeles sues 3 companies over toxic PCBs in waterwayssandiegouniontribune.com
- 128Town of Lee sues Bayer company over Monsanto's role in manufacturing PCBs sold to General Electric Co.berkshireeagle.com
- 129U.S. Federal Appeals Court Upholds $25m Monsanto Roundup Cancer Verdictprnewswire.com
- 130Vermont attorney general sues Monsanto over PCBs in schools and the environment - VTDiggervtdigger.org
- 131Vermont’s largest city sues Monsanto over school contaminationpressherald.com
Cite this profile: Cite the canonical profile. /brandpedia/bayer · Editorial policy · How profiles are compiled